Expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
Lancet Neurol
.
2022 Mar;21(3):210.
doi: 10.1016/S1474-4422(22)00030-8.
Epub 2022 Jan 18.
Author
The Lancet Neurology Editors
1
Affiliation
1
The Lancet Neurology, London EC2Y 5AS, UK.
PMID:
35063117
DOI:
10.1016/S1474-4422(22)00030-8
No abstract available
Publication types
Expression of Concern